Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 11/20 | 0.96 |
| ▸ | HSP90AA1 | P07900 | 5/20 | 0.96 |
| ▸ | LMNA | P02545 | 4/20 | 0.96 |
| ▸ | MAPT | P10636 | 4/20 | 0.96 |
| ▸ | METAP2 | P50579 | 2/20 | 0.96 |
| ▸ | METAP1 | P53582 | 2/20 | 0.96 |
| ▸ | BRD4 | O60885 | 1/20 | 0.96 |
| ▸ | HTT | P42858 | 4/20 | 0.62 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.62 |
| ▸ | MMP14 | P50281 | 3/20 | 0.62 |
| ▸ | MEN1 | O00255 | 3/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.62 |
| ▸ | TP53 | P04637 | 2/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.62 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.62 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cloxyquin SCHEMBL115838 | 0.98 | KDM4E (1.00) | KDM4EHSP90AA1LMNAMAPTMETAP2 | |
| Cloxyquin SCHEMBL29381298 | 0.98 | KDM4E (1.00) | KDM4EHSP90AA1LMNAMAPTMETAP2 | |
| Cloxyquin SCHEMBL317736 | 0.96 | KDM4E (0.96) | KDM4EHSP90AA1LMNAMAPTMETAP2 | |
| Cloxyquin SCHEMBL360578 | 0.96 | KDM4E (0.96) | KDM4EHSP90AA1LMNAMAPTMETAP2 | |
| Cloxyquin SCHEMBL4776305 | 0.96 | KDM4E (0.96) | KDM4EHSP90AA1LMNAMAPTMETAP2 | |
| Cloxyquin SCHEMBL4977294 | 0.96 | KDM4E (0.96) | KDM4EHSP90AA1LMNAMAPTMETAP2 | |
| Cloxyquin SCHEMBL4978867 | 0.96 | KDM4E (0.96) | KDM4EHSP90AA1LMNAMAPTMETAP2 | |
| Cloxyquin SCHEMBL4292402 | 0.96 | KDM4E (0.96) | KDM4EHSP90AA1LMNAMAPTMETAP2 | |
| Cloxyquin SCHEMBL4302919 | 0.96 | KDM4E (0.96) | KDM4EHSP90AA1LMNAMAPTMETAP2 | |
| Cloxyquin SCHEMBL4977328 | 0.96 | KDM4E (0.96) | KDM4EHSP90AA1LMNAMAPTMETAP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7514158-B2 | Coumarin compound | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 2009-04-07 | — | — | US | disclosed |
| US-20070018568-A1 | Organic electroluminescent device | KABUSHIKI KAISHA TOYOTA JIDOSHOKKI (JP) | 2007-01-25 | — | — | US | disclosed |
| US-20060228577-A1 | Organic electroluminescent device | KABUSHIKI KAISHA TOYOTA JIDOSHOKKI (JP) | 2006-10-12 | — | — | US | disclosed |
| US-20050275341-A1 | Coumarin compound | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 2005-12-15 | — | — | US | disclosed |
| EP-1599074-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | Kabushiki Kaisha Toyota Jidoshokki (JP) | 2005-11-23 | — | — | EP | disclosed |
| EP-1560469-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | Kabushiki Kaisha Toyota Jidoshokki (JP) | 2005-08-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050275341-A1 | Coumarin compound | XPO1, VKORC1, XPO5 | KDM4E 3068/4885HSP90AA1 1820/4885LMNA 560/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.